The EU Commission approves, subject to remedies, a merger in the medical devices market giving a practical example of the use of quantitative analyses in merger control (GE Medical Systems / Instrumentarium)

"GE/Instrumentarium: a practical example of the use of quantitative analyses in merger control"* On 2 September 2003, the European Commission approved, subject to conditions, the acquisition by General Electric Medical Systems (‘GE’) of the Finnish firm Instrumentarium. The Commission was concerned that GE and Instrumentarium would hold too high a share of the patient monitoring market, which would have been detrimental to hospitals. The Commission’s concerns were removed following GE’s offer to sell off Spacelabs, a one-year-old acquisition by Instrumentarium, together with a series of supply agreements, as well as the commitment to ensure interoperability of its anaesthesia equipment, patient monitors and clinical information systems with third parties’ devices. This case illustrates

L'accès à cet article est réservé aux abonnés

Déjà abonné ? Identifiez-vous

L’accès à cet article est réservé aux abonnés.

Lire gratuitement un article

Vous pouvez lire cet article gratuitement en vous inscrivant.

 

Version PDF

Auteurs

Citation

Benoît Durand, Guillaume Loriot, François-Xavier Rouxel, The EU Commission approves, subject to remedies, a merger in the medical devices market giving a practical example of the use of quantitative analyses in merger control (GE Medical Systems / Instrumentarium), 2 septembre 2003, e-Competitions September 2003, Art. N° 38385

Visites 348

Tous les numéros

  • Latest News issue 
  • Tous les News issues
  • Latest Special issue 
  • Tous les Special issues